Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 4;7(1):690.
doi: 10.4102/ajlm.v7i1.690. eCollection 2018.

Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi

Annie Zhang  1 , Enoch Jumbe  2 , Robert Krysiak  3 , Sabeen Sidiki  4 , Holden V Kelley  4 , Elly K Chemey  2 , Chancy Kamba  5 , Victor Mwapasa  6 , Juan I García  7 , Alison Norris  8 , Xueliang J Pan  9 , Carlton Evans  10   11 , Shu-Hua Wang  12 , Jesse J Kwiek  1 , Jordi B Torrelles  4
Affiliations

Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi

Annie Zhang et al. Afr J Lab Med. .

Abstract

Background: Rural settings where molecular tuberculosis diagnostics are not currently available need easy-to-use tests that do not require additional processing or equipment. While acid-fast bacilli (AFB) smear is the most common and often only tuberculosis diagnosis test performed in rural settings, it is labour intensive, has less-than-ideal sensitivity, and cannot assess tuberculosis drug susceptibility patterns.

Objective: The objective of this study was to determine the feasibility of a multidrug-resistant (MDR) or extensively drug-resistant (XDR)-tuberculosis coloured agar-based culture test (tuberculosis CX-test), which can detect Mycobacterium tuberculosis growth and evaluate for drug susceptibility to isoniazid, rifampicin and a fluoroquinolone (i.e. ciprofloxacin) in approximately 14 days.

Method: In this study, 101 participants were enrolled who presented to a rural health clinic in central Malawi. They were suspected of having active pulmonary tuberculosis. Participants provided demographic and clinical data and submitted sputum samples for tuberculosis testing using the AFB smear and tuberculosis CX-test.

Results: The results showed a high level of concordance between the AFB smear (12 positive) and tuberculosis CX-test (13 positive); only one sample presented discordant results, with the molecular GeneXpert MTB/RIF® test confirming the tuberculosis CX-test results. The average time to a positive tuberculosis CX-test was 10 days. Of the positive samples, the tuberculosis CX-test detected no cases of drug resistance, which was later confirmed by the GeneXpert MTB/RIF®.

Conclusion: These findings demonstrate that the tuberculosis CX-test could be a reliable low-cost diagnostic method for active pulmonary tuberculosis in high tuberculosis burden rural areas.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships which may have inappropriately influenced them in writing this article.

Figures

FIGURE 1
FIGURE 1
The tuberculosis CX-test.
FIGURE 2
FIGURE 2
Time to positive tuberculosis CX-test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization 2015 Malawi tuberculosis profile [homepage on the Internet]. c2015 [cited 2017 Jul 10]. Available from: https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/...
    1. Cepheid Xpert MTB/RIF [homepage on the Internet]. c2015 [cited 2015 Mar 16]. Available from: http://www.cepheid.com/us/cepheid-solutions/clinical-ivd-tests/critical-...
    1. World Health Organization 2014 Malawi tuberculosis profile. Geneva, Switzerland: World Health Organization; 2014.
    1. Centers for Disease Control and Prevention Introduction to the core curriculum on tuberculosis: What the clinician should know. Atlanta, GA: CDC Stacks Public Health Publications; 2013, p. 92–94.
    1. Evans CA. GeneXpert--a game-changer for tuberculosis control? PLoS Med. 2011;8:e1001064 https://doi.org/10.1371/journal.pmed.1001064 - DOI - PMC - PubMed